News

AMSilk tailoring proteins for performance textiles

16/02/2023
AMSilk tailoring proteins for performance textiles

Synthetic silk biopolymer developer AMSilk has joined hands with Brain Biotech, a manufacturer of bioactives and speciality enzymes also based in Germany, in a bid to optimise and expand its protein technology platform to better meet the demands of performance textile fibres.

To continue reading this story, please sign in or register.

Related stories:

AMSilk secures €52 million to boost scale-up 09/09/2025
AMSilk heads to France 23/10/2024
Biotech silk readies for commercialisation 21/06/2024
Partnership spins new chapter for ‘spider silk’ proteins 22/01/2024
Stella McCartney uses enzyme process for parka 07/12/2023
AMSilk fundraising will help meet market demand for biopolymers 11/04/2023
Adidas harnesses NASA-born superpolymer 15/03/2023
Adidas expects a year of decline ahead 08/03/2023
Origin and Avantium team up to advance plant PEF 24/02/2023
Re-spun silkworm silk 70% stronger than spider silks, research finds 10/11/2022
Move to new HQ will support expansion, AMSilk says 02/11/2022
Tech adoption will determine functional fibres’ sustainability, industry says 01/08/2022
Video offers behind-the-scenes insight into spider silk operation 26/07/2022
Major cash injection for Activated Silk maker 30/06/2022
Kraig Labs selects Spydasilk producer 29/06/2022
Spiber and Pangaia brew first-of-a-kind hoodie 08/06/2022
Chongqing spurs sericulture with subsidies 19/04/2022

Sportstextiles.com cannot be held responsible for content if the language setting is changed from English.

The translations provided by Google Translate are automated and therefore might not be accurate and may contain incorrect, offensive or misleading language. We offer this facility as a guide only.